医药制造业
Search documents
大连2025年地区生产总值同比增长5.7%,成为东北地区首个GDP突破万亿元城市
Zheng Quan Shi Bao Wang· 2026-01-23 04:59
1月23日,大连市政府新闻办召开新闻发布会,介绍2025年全市经济运行情况。 2025年,大连市的投资结构持续优化,制造业投资小幅增长。全年全市制造业投资同比增长2.8%,基 础设施投资同比下降11.9%,工业企业技术改造投资同比增长14.5%,建设项目投资同比下降13.2%,设 备工器具购置投资同比增长9.2%,民间投资同比下降14.1%。 此外,大连市消费市场扩容增效,提振消费政策成效显现;财税运行稳中提质,民生支出占比提升;消 费价格低位运行,食品烟酒价格降幅较深。 总的来看,2025年大连市经济保持平稳运行,高质量发展取得新成效,"十四五"规划主要预期目标如期 实现。 2025年,大连市农业生产总体稳定,农产品供应充足,全年全市第一产业增加值665.4亿元,同比增长 3.6%。蔬菜及食用菌产量208.1万吨,增长3.6%;水果产量219.3万吨,增长4.3%,比上年同期提高2.7个 百分点。地方水产品产量287.3万吨,增长5.1%。其中,海水养殖244.6万吨,增长4.8%。 工业保持较快增长,装备制造业支撑有力。2025年,大连市规上工业增加值同比增长11.7%,比上年同 期提高4.1个百分点,工 ...
云南曲靖:产业强基筑高地 向新而行启新程
Zhong Guo Jin Rong Xin Xi Wang· 2026-01-22 07:37
"十四五"期间,云南省曲靖市以产业链重构破解发展瓶颈,以科技创新激活产业动能,在绿色铝、生物医药等关键领域实现突破。站在"十五五" 谋篇布局 的新起点,曲靖市正锚定"高端化、智能化、绿色化"方向,全力书写高质量跨越式发展新篇章。 绿色铝产业:从"卖原铝"到"造精品"闭环产业链闯出升级路 转自:新华财经 走进富源产业园区程林机械的高端铝板生产车间,智能化生产线全速运转,火红的铝液经过精炼、铸造、热轧等工序,摇身变成食品级高端铝板,随即被输 送到隔壁厂房,加工成出口东南亚的高端铝锅。 图为云铝泽鑫厂区全景航拍(资料图)。(曲靖市融媒体中心供图) 科技创新赋能下,曲靖高端铝材料不仅供应国内新能源汽车、航空航天等高端制造领域,更远销东南亚、欧洲市场。数据显示,2025年富源铝产业产值突破 100亿元,同比增长5.7%,是2020年的1.54倍;进出口贸易额超4亿元,同比增长184%,是2020年的12倍。 "车间对车间"的无缝衔接,让这家三年前才在曲靖市富源县落户的企业,2025年上半年产值就突破7000万元,产出各类厨具120万件。而这,正是曲靖绿色 铝产业"破茧成蝶"的生动缩影。 时间拉回"十四五"开局,曲靖绿色 ...
2025年北京规上工业增加值同比增长6.5% 出口交货值同比增长6.4%
Bei Jing Shang Bao· 2026-01-21 02:27
北京商报讯(记者 和岳)1月21日,北京市统计局发布2025年北京经济运行情况,2025年,全市规模以 上工业增加值按可比价格计算,比上年增长6.5%。重点行业中,计算机,通信和其他电子设备制造 业,汽车制造业分别增长20.2%和17.7%,新能源汽车,消费电子,集成电路等领域发挥带动作用;电 力,热力生产和供应业增长5.5%;医药制造业下降8.6%;五大装备制造业'增长4.9%。实现规模以上工 业出口交货值2113.4亿元,增长6.4%,其中汽车制造业,专用设备制造业分别增长24.6%和10.8%。 ...
金陵药业股份有限公司 关于召开2026年第一次临时股东会的通知
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2026-01-20 23:35
登录新浪财经APP 搜索【信披】查看更多考评等级 一、召开会议的基本情况 (一)股东会届次:2026年第一次临时股东会 (二)股东会的召集人:董事会 金陵药业股份有限公司 (四)会议时间: 1、现场会议时间:2026年2月5日14:30 关于召开2026年第一次临时股东会的通知 (三)本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易所股票上市规则》《深圳 证券交易所上市公司自律监管指引第1号一一主板上市公司规范运作》等法律、行政法规、部门规章、 规范性文件及《公司章程》的有关规定。 证券代码:000919 证券简称:金陵药业 公告编号:2026-004 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗 漏。 ■ 2、网络投票时间:通过深圳证券交易所系统进行网络投票的具体时间为2026年2月5日9:15-9:25,9:30- 11:30,13:00-15:00;通过深圳证券交易所互联网投票系统投票的具体时间为2026年2月5日9:15至15:00 的任意时间。 (五)会议的召开方式:现场表决与网络投票相结合。 (六)会议的股权登记日:2026年1月30日 ...
【数读IPO】去年净利最高预增超40% 智能制造装备供应商今日申购
Xin Lang Cai Jing· 2026-01-20 23:17
智通财经1月21日讯,今日有1只新股申购,为北交所的美德乐;1只新股上市,为北交所的爱舍伦。 今日申购新股 美德乐主营智能制造装备的研发、设计、制造和销售业务,主要产品为模块化输送系统和工业组件。相关产品通过与智能生产设备深度融合,实现生产设备 与自动化装配线的集成应用,是智能工厂建设的重要组成部分,广泛应用于新能源、汽车零部件、电子、仓储物流等行业领域。公司主要客户或终端客户包 括先导智能、海目星、今天国际、先惠技术、昆船智能、联赢激光、博众精工、机器人、长园集团等知名系统解决方案供应商,以及比亚迪、宁德时代、信 质集团等新能源电池、汽车零部件制造行业领军企业 公司2022-2024年营业收入分别为10.31亿元、10.09亿元、11.38亿元;净利润分别为2.225亿元、2.052亿元、2.108亿元。公司预计2025年营收13亿元至14亿 元,同比变动14.26%至23.05%;预计归母净利润2.7亿元至3亿元,同比变动28.11%至42.34% 今日上市新股 公司2022-2024年营业收入分别为5.736亿元、5.747亿元、6.916亿元;净利润分别为6280万元、6696万元、8071万元。20 ...
欧康医药:关于公司再次通过高新技术企业认定的公告
Zheng Quan Ri Bao· 2026-01-20 12:12
(文章来源:证券日报) 证券日报网讯 1月20日,欧康医药发布公告称,公司于近日收到由四川省科学技术厅、四川省经济和信 息化厅、四川省财政厅、国家税务总局四川省税务局联合颁发的《高新技术企业证书》,证书编号: GR202551003919,有效期:三年。本次系公司持有的原高新技术企业证书有效期届满后进行的重新认 定。 ...
盘前公告淘金:复牌!上海国资拟入主江化微,华是科技实控人变更、盈方微重大资产重组;湖南裕能2025年净利同比预增94%-136%
Jin Rong Jie· 2026-01-20 01:43
Important Events - Yidian Tianxia has resumed trading after the suspension for verification [1] - Jianghuai Microelectronics will have its actual controller changed to Shanghai State-owned Assets Supervision and Administration Commission, and its stock has resumed trading [1] - Huas Technology's actual controller has changed to Zheng Jianbo, and its stock has resumed trading [1] - Yingfang Microelectronics plans to acquire 100% shares of Shanghai Xiaokeli and Fujide China, which is expected to constitute a major asset restructuring, and its stock has resumed trading [1] - Hualing Cable has terminated the acquisition of Xingxin Aerospace's controlling stake, which provides supporting products for Shenzhou series spacecraft, Chang'e series detectors, and various launch vehicles [1] - Rongsheng Development's subsidiary plans to acquire 100% equity of Yingde Jihong and Yingde Jiyue for 40 million yuan [1] - Donghua Software plans to establish a wholly-owned subsidiary, Donghua Zhizhi, with an investment of 300 million yuan [1] - Zhongwei Semiconductor is about to launch its first non-volatile memory chip [1] - Xingqi Eye Medicine's SQ-24071 eye drops have received clinical trial approval [1] Contracts & Project Bids - Pingzhi Information has pre-qualified for an intelligent computing service project worth approximately 489 million yuan [1] - Nanshan Aluminum plans to invest 437 million USD to build a 250,000-ton annual electrolytic aluminum project in Indonesia [1] - Yian Technology's controlling company has signed a project entry contract to create a benchmark project for high-quality amorphous alloy (liquid metal) [1] - Jiangxi Copper has signed a three-year cooperation framework agreement with the Ordnance Material Department, expecting to sell 9.7 billion yuan worth of copper rods and other products annually [1] - Wutong Holdings' wholly-owned subsidiary did not win the bid for the Agricultural Bank of China mobile SMS long number agency service project, which is expected to have a significant adverse impact on the company's future operating performance [1] Operations & Performance - Hunan Yuneng expects a net profit increase of 94%-136% year-on-year in 2025, driven by a rebound in lithium carbonate prices enhancing overall profitability [1] - Jilin Carbon Valley anticipates a net profit increase of 92.81%-135.66% year-on-year in 2025 [1] - Fulai Anticipates a net profit increase of 81.67%-127.08% year-on-year in 2025 [1] - Dingtong Technology expects a net profit increase of 120% year-on-year in 2025, with significant growth in high-speed communication product business [1] - Chengdu Huamei anticipates a net profit increase of 74%-109% year-on-year in 2025, with Q4 net profit expected to grow by 458%-614% quarter-on-quarter [1] - Anfu Technology expects a net profit increase of 28.55%-50.91% year-on-year in 2025 [1] - Dinglong Co. anticipates a net profit increase of 34.44%-40.20% year-on-year in 2025 [1] - Mingtai Aluminum expects a net profit increase of 12%-14% year-on-year in 2025 [1] - Huace Testing anticipates a net profit increase of 10%-11% year-on-year in 2025 [1] - Xianglu Tungsten Industry expects a net profit of 125 million to 180 million yuan in 2025, with tungsten metal raw material prices continuing to rise throughout the year [1] Financing & Capital Increase - Jiangxi Copper plans to register and issue debt financing instruments not exceeding 25 billion yuan [2] - Goldwind Technology has terminated the public REITs application and issuance work [2] - Huichuan Technology is planning to issue H-shares and list on the Hong Kong Stock Exchange [2]
2025年中国经济数据点评:中国经济的亮点和星光
ZHONGTAI SECURITIES· 2026-01-19 14:27
Economic Growth - In Q4 2025, China's GDP grew by 4.5% year-on-year, aligning with market expectations, achieving a full-year GDP growth of 5.0%[2] - The contribution rates of final consumption expenditure, gross capital formation, and net exports to GDP changed from 44.5%, 25.2%, and 30.3% in 2024 to 52.0%, 15.3%, and 32.7% in 2025, respectively[2] Consumption and Investment - Final consumption expenditure's contribution to economic growth exceeded 50% due to the "trade-in" policy, with retail sales growth rising from 3.5% in 2024 to 3.7% in 2025[2] - Fixed asset investment decreased by 3.8% year-on-year in 2025, which indirectly boosted the contribution of final consumption to economic growth[2] Industrial Performance - Industrial value-added growth in December 2025 rose to 5.2% from 4.8% in November, while the service production index increased from 4.2% to 5.0%[2] - High-tech industry value-added growth reached 11.0% in December 2025, marking the highest level for the year, with an annual growth of 9.4% compared to 8.9% in 2024[2] Capacity Utilization and Real Estate - China's industrial capacity utilization rate increased from 74.6% in Q3 2025 to 74.9% in Q4 2025, but was down 1.3 percentage points year-on-year, the largest decline since Q2 2023[2] - Real estate indicators showed a narrowing decline, with property sales area and value improving from -17.0% and -24.6% in November to -15.5% and -23.5% in December 2025[3] Policy Outlook - The report suggests that structural highlights in the economy are emerging, but the "strong supply, weak demand" situation persists, necessitating continued policy support[3] - The central bank's structural interest rate cuts and expanded lending in January 2026 indicate a clear intention for a more accommodative credit policy to stimulate economic growth[3]
利润下滑,2家公司北交所IPO终止辅导!
Sou Hu Cai Jing· 2026-01-19 13:58
1月19日,新三板挂牌公司佳音科技(874629)公告披露,因现阶段公司经营情况及后续战略规划需要,公司拟对上市计划 进行调整,甬兴证券已于2026年1月15日向宁波证监局报送了关于公司终止辅导备案的申请材料,宁波证监局已于2026年1 月19日确认公司终止辅导。 佳音科技2001年成立,主营业务为各品类泵类产品、阀类产品、传感器类产品等小家电、家用电器的核心零部件、智能零 部件及其他小家电相关OEM产品的研发、生产与销售。 同行业可比公司包括宏昌科技、三花智控、汉宇集团。 2025年1-6月,公司营业收入48,670.80万元,同比增长46.93%;归属于挂牌公司股东的净利润2,952.63万元,同比下降 9.23%;归属于挂牌公司股东的扣非净利润2,812.00万元,同比下降8.75%。 公司实际控制人为鲁定尧及其配偶陈芝波,二人合计控制公司87.03%的表决权。 另一家新三板挂牌公司伊普诺康(835852)同日公告披露,近期,由于我公司自身发展战略规划等需要,经双方协商一 致,决定终止本次上市辅导工作,国元证券于2026年1月15日向安徽证监局报送了终止辅导的申请资料,安徽证监局于2026 年1月16日 ...
绽妍生物拟北交所上市:70后副总王昆操作员出身,曾是董事长同事
Sou Hu Cai Jing· 2026-01-19 01:15
Company Overview - Zhan Yan Biotechnology Co., Ltd. was established on December 6, 2019, with a registered capital of 61.62 million yuan and is located in Chengdu, Sichuan, China [1] - The company is primarily engaged in the research, production, and sales of biomedical materials, dermatological skincare products, and bioactive raw materials [1] - The controlling shareholder is Zhang Yingting, who directly holds 62.1551% of the company's shares [1] IPO and Financial Performance - Zhan Yan Biotechnology has completed its IPO counseling registration with the Sichuan Securities Regulatory Bureau and plans to list on the Beijing Stock Exchange [1] - The company aims to be listed on the New Third Board by September 2025 [1] - Projected revenues for 2023 and 2024 are 486 million yuan and 597 million yuan, respectively, with net profits of 68.48 million yuan and 73.50 million yuan [2][3] - The gross profit margins for 2023 and 2024 are expected to be 62.33% and 68.34%, respectively [2][3] Shareholding Structure - As of the date of the public transfer prospectus, Zhang Yingting directly holds 62.16% of the shares and, through concerted actions, controls 91.22% of the voting rights [3] - Other shareholders include Yang Fengle, who holds 17.79%, and Hengqin Zhan Yan, an employee stock ownership platform, which holds 11.28% [3] - Wang Kun directly holds 4.06% and indirectly holds 0.24%, while Tax Ke Ying directly holds 0.41% and indirectly holds 0.31% [4] Management Team - Zhang Yingting serves as the Chairman and Manager of the company [5] - Wang Kun is the Director and Deputy Manager, while Tax Ke Ying is the Secretary of the Board and Chief Financial Officer [5] - The management team has extensive experience in the pharmaceutical and biotechnology sectors, with backgrounds in various companies prior to joining Zhan Yan Biotechnology [6][7][8]